Laryngeal cancer


Early symptoms of throat cancer
Laryngeal cancer is a relatively common type of malignant tumor in the head and neck region. In terms of clinical symptoms, if it is early-stage laryngeal cancer, there may not be obvious clinical manifestations. This condition is usually discovered during physical examinations or laryngoscopic examinations. Some patients may experience hoarseness, sore throat, a foreign body sensation in the throat, or possibly swallowing obstruction and difficulty breathing. Once these symptoms appear, a laryngoscopic examination is necessary. Generally, the scope of the condition can be preliminarily judged through laryngoscopic examination, and surgical treatment or radiation therapy can typically be considered.


Stage II throat cancer is the situation.
The so-called Stage II laryngeal cancer refers to the degree of differentiation of cancer cells, classified as moderately malignant. This type of differentiated cancer cells has a tumor growth rate that is between Stage I and Stage III, and shows certain characteristics of invasion and metastasis. Stage II laryngeal cancer generally tends to metastasize via the lymphatic pathways, and some patients may also experience hematogenous pathway metastasis. Clinically, patients with Stage II laryngeal cancer may present with symptoms localized to the larynx as well as symptoms of metastatic sites. Patients may experience symptoms such as hoarseness, cough, expectoration, and a foreign body sensation in the throat. When metastasis occurs, respiratory symptoms like coughing and coughing up blood can appear.


Can throat cancer be contagious?
Laryngeal cancer is not contagious. Current medical evidence and research indicate that laryngeal cancer does not have a definitive contagious nature. There are many factors involved in the onset of laryngeal cancer, and clinically, the possible inducing factors have not been completely determined yet. These factors may include having a family history, or frequent exposure to radioactive or chemical substances, as well as potentially due to long-term smoking and drinking, which are risk factors that could lead to the disease. Overall, the exact cause of the disease is not particularly clear, but regardless of the factor, no contagious nature has been found. Therefore, laryngeal cancer is not infectious and is not considered a communicable disease. In terms of treatment, surgery is primarily considered, and some cases may also require consideration of radiotherapy or chemotherapy. Generally, it is regarded as a relatively common malignant tumor of the head and neck.


Pre-cancerous symptoms of throat cancer
Laryngeal cancer is a common disease in otolaryngology and a type of malignant tumor, which is divided into primary laryngeal cancer and secondary laryngeal cancer. The main clinical symptoms of laryngeal cancer in its early stages often include hoarseness, cough, and lymph node enlargement, among others. Patients can use indirect laryngoscopy or electronic nasopharyngoscopy to detect tumors located in the pharyngeal area, and a local pathological biopsy can be performed for diagnosis. When the tumor is identified as malignant, it is essential to initiate prompt and active treatment. The common method is to surgically remove the detected tumor to achieve clinical cure.


What causes throat cancer?
Throat cancer is a malignant tumor that occurs in the throat area. Its causes are not clear, but it is generally associated with long-term smoking, drinking, exposure to toxic and carcinogenic substances, as well as gastrointestinal dysfunction, acid reflux irritation, prolonged loud speaking, staying up late, fatigue, and malignant transformation of benign tumors, which lead to symptoms in the throat area. It causes persistent hoarseness in patients, and the symptoms progressively worsen. Patients may also experience a foreign body sensation in the throat, a feeling of blockage, a burning sensation, and sometimes difficulty swallowing. Patients should first go to the hospital for a detailed examination with an electronic laryngoscope, which can reveal cauliflower-like neoplasms or ulcers in any part of the throat. If such findings are present, a local biopsy is needed. If the biopsy confirms the presence of a malignant tumor, local surgery, radiotherapy, or chemotherapy is required for treatment.


Can early-stage throat cancer be cured?
If we are talking about early-stage laryngeal cancer, generally speaking, the cure rate is relatively high. The main treatment methods for early-stage laryngeal cancer are primarily surgical, although radiation therapy can also be considered for some patients. However, specific treatments still need to be tailored according to the patient's own condition and the pathological staging and typing. If the cancer is well-differentiated, the treatment outcomes are generally better. If it is poorly differentiated or moderately differentiated, even though it is early-stage laryngeal cancer, the cure rate is relatively lower, especially within the first two years and the first five years. If a five-year survival rate is achieved without evident recurrences or metastases, this is considered a standard for clinical cure. However, regular follow-ups are still necessary due to the potential risk of recurrence.


Is the embryonic antigen high in throat cancer?
Throat cancer is a relatively common otolaryngology disease and also belongs to a common type of head and neck malignant tumor. Generally, the carcinoembryonic antigen does not show obvious elevation because, currently, there are no characteristic tumor markers for throat cancer. Diagnosis is mainly based on the clinical experience of doctors, combined with laryngoscopic examination and CT scan of the throat area. For patients with throat cancer, it is advised to promptly visit an otolaryngology clinic after the onset of the disease and undergo related auxiliary examinations to clarify the specific extent of the condition. Common treatment methods include surgery, radiotherapy, and chemotherapy. A targeted treatment plan should be chosen based on the clinical staging of the patient.


Do people with throat cancer lose weight?
Throat cancer is a relatively common type of malignant tumor in the head and neck area. Some patients may experience weight loss, which can be due to the condition of throat cancer itself, swallowing obstruction caused by the cancer leading to malnutrition, or excessive consumption of the body. Therefore, it is essential for patients with throat cancer to seek prompt medical attention from an otolaryngologist after onset, assess the severity of the condition, and consider comprehensive treatment options such as surgery or radiochemotherapy. During treatment, it is crucial to enhance nutrition, regularly review the condition, and observe changes in the disease. Overall, the treatment outcomes for early-stage throat cancer are relatively good.


Does throat cancer require the removal of the throat?
Laryngeal cancer is a malignant tumor in the larynx, clinically mainly squamous cell carcinoma. The treatment of laryngeal cancer primarily involves comprehensive treatment centered around surgery, which is adapted according to the type of laryngeal cancer the patient has and the extent of the lesion. For some early-stage tumors, such as carcinoma in situ or T1 stage tumors, treatment often involves local removal with a laser or radiation therapy, after which a cure is achieved without the need for partial or total laryngectomy. This approach preserves the function of the larynx, especially the function of phonation. In summary, the treatment of laryngeal cancer should be based on its specific circumstances and does not necessarily involve the removal or excision of the larynx.


Recurrence rate after total laryngectomy for throat cancer
Laryngeal cancer is a common disease in otolaryngology and a relatively prevalent malignant tumor. Patients who undergo total laryngectomy often have advanced laryngeal tumors, which block the esophagus or pharynx and have tumor tissues too large for partial removal. The likelihood of recurrence after tumor resection varies from patient to patient, depending on the radiotherapy and chemotherapy administered post-operatively, as well as individual physical constitutions, which can alter recurrence rates. Generally, we recommend that patients undergo a laryngoscopic check-up every three to six months and a CT scan of the larynx post-surgery, to enable timely detection and treatment, aiming for early control and intervention in case of potential recurrence.